Blood Res.  2023 Dec;58(4):228-231. 10.5045/br.2023.2023189.

TP53 mutation is a high-risk factor for RichterÊs syndrome based on circulating tumor DNA

• Park HS
• Son BR
• Son SM
• Kwon J

• KMID: 2550202
• DOI: http://doi.org/10.5045/br.2023.2023189

Figure

• 

  Fig. 1 Clinical assessment over treatment timeline. (A) Initial bone marrow aspiration showed highly increased levels of small mature lymphocytes. Initial diagnosis: CLL (BM, Wright stain, ×1,000). (B) New tumor lesion in left arm (cutaneous DLBCL). (C) Peripheral WBC count and absolute lymphocyte counts.

Reference

1. Ben-Dali Y, Hleuhel MH, da Cunha-Bang C, et al. 2020; Richter's transformation in patients with chronic lymphocytic leukemia: a nationwide epidemiological study. Leuk lymphoma. 61:1435–44. DOI: 10.1080/10428194.2020.1719092. PMID: 32031030.

2. Jain P, O'Brien S. 2012; Richter's transformation in chronic lymphocytic leukemia. Oncology. 26:1146.

3. Parry EM, Leshchiner I, Guièze R, et al. 2023; Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome. Nat Med. 29:158–69. DOI: 10.1038/s41591-022-02113-6. PMID: 36624313. PMCID: PMC10155825.

4. Nadeu F, Royo R, Massoni-Badosa R, et al. 2022; Detection of early seeding of Richter transformation in chronic lymphocytic leukemia. Nat Med. 28:1662–71. DOI: 10.1038/s41591-022-01927-8. PMID: 35953718. PMCID: PMC9388377.

5. Scherer F, Kurtz DM, Newman AM, et al. 2016; Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA. Sci Transl Med. 8:364ra155. DOI: 10.1126/scitranslmed.aai8545. PMID: 27831904. PMCID: PMC5490494.

6. Rossi D, Spina V, Gaidano G. 2018; Biology and treatment of Richter syndrome. Blood. 131:2761–72. DOI: 10.1182/blood-2018-01-791376. PMID: 29692342.

7. Rossi D, Spina V, Deambrogi C, et al. 2011; The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation. Blood. 117:3391–401. DOI: 10.1182/blood-2010-09-302174. PMID: 21266718.

8. Yun X, Zhang Y, Wang X. 2020; Recent progress of prognostic biomarkers and risk scoring systems in chronic lymphocytic leukemia. Biomark Res. 8:1–11. DOI: 10.1186/s40364-020-00222-3. PMID: 32939265. PMCID: PMC7487566. PMID: 6ec286995b4a459d9b3078094f752aba.

9. Yeh P, Hunter T, Sinha D, et al. 2017; Circulating tumor DNA reflects treatment response and clonal evolution in chronic lymphocytic leukemia. Nat Commun. 8:14756. DOI: 10.1038/ncomms14756. PMID: 28303898. PMCID: PMC5357854. PMID: a5d0115fb7e149b29d91aa033cf28281.

10. Chigrinova E, Rinaldi A, Kwee I, et al. 2013; Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome. Blood. 122:2673–82. DOI: 10.1182/blood-2013-03-489518. PMID: 24004666.